SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
QLT PhotoTherapeutics (QLTI)
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1321 51 0 QLTI
Emcee:  Doug Lakin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1321Insider buys $1 million QLTI Qlt Inc/bc Schonharting Florian (10% Ownejeeee4-3/17/2010
1320QLT closes book on past to ramp up ocular drug development biotuesday.cjeeee4-3/4/2010
1319My guess would be some preliminary feelers which were rebuffed and didn't reIan@SI-8/29/2006
1318>>QLT Denies It Got Reported Buyout Offer Tuesday August 29, 3:52 pm ET tuck-8/29/2006
13171:03 (Dow Jones) QLT (QLTI) shares get a boost from a Globe and Mail newspaper rIan@SI-8/29/2006
1316<b>Private equity pursues takeout of QLT </b> ANDREW WILLIS AND LEONIan@SI-8/29/2006
1315QLT announces co-development and licensing agreement with Retinagenix for early Doc Bones-4/5/2006
1314Munch rumours... QLT options soar on takeover talk LEONARD ZEHR Speculation oIan@SI-12/30/2005
1313Visudyne sales decline quarter-over-quarter: tinyurl.comDewDiligence_on_SI-10/18/2005
1312CC notes: investorshub.comDewDiligence_on_SI-9/26/2005
1311Eligard is losing traction, too, but there is some other stuff. Early and middltuck-9/26/2005
1310It’s unlikely that a new CEO will help. The real problem is that Visudyne is an DewDiligence_on_SI-9/26/2005
1309Given that the eye care franchise is beset on all sides, it's important. QLtuck-9/26/2005
1308Thanks for that. How big is this news, iyo? Fox.twentyfirstcenturyfox-7/16/2005
1307[ACZONE approved] >>VANCOUVER, July 7 /PRNewswire-FirstCall/ - QLT Inc. (tuck-7/7/2005
1306QLTI recommended yesterday by Michael Murphy - technology investing online.RMP-6/17/2005
1305Thanks for the pointer to Charly's article. Clearly if the "whole streIan@SI-3/29/2005
1304Charley of MF makes the value case today: fool.com I agree that risk/reward ltuck-3/29/2005
1303QLT Recommendation upgrade. 11-Mar-2005 09:04 PM QLT Consensus recommendationSultan-3/11/2005
1302Tuck, Biotech is too unloved lately. I'll watch.Ian@SI-3/8/2005
1301Besides Macugen, competitive threats getting closer, i.e. Lucentis? Dew's stuck-3/8/2005
1300Anyone have an idea why this stock is in free fall mode? M/b a good buy opportunzakaran-3/8/2005
1299[QLT0254 & pancreatic cancer] >>Cancer Res. 2005 Feb 15;65(4):1497-50tuck-3/1/2005
1298Looks like an Acne treatment product is about to be approved... Key Data to be Ian@SI-2/18/2005
1297I read Eyetech quarterly report. I have decided to take positions in QLTI. I tbrian h-2/16/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News